Capital Raising Through a Public Offering in Connection with the Listing
First written in FY2019-Q1. 14 of 15 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2023-Q2.
25 other companies' latest entry also says "Advanced".
- FY2023-Q2AdvancedAnnual report
「This was mainly attributable to a ¥67.524 million increase in capital surplus resulting from a third-party allotment and the recognition of ¥65.867 million in net income attributable to owners of the parent.」
The third-party allotment increased capital surplus by ¥67.524 million, with specific changes related to capital raising described. - FY2022AdvancedAnnual report
「1 April 2021–31 March 2022 Common shares 41,720 Common shares 4,749,860 23,271 879,556 23,271 864,556」
The exercise of share acquisition rights resulted in the issuance of 41,720 shares and increased both stated capital and capital surplus by ¥23.271 million. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) Increase resulting from the exercise of share acquisition rights. 13,300 4,749,860 6,198 879,556 6,198 864,556」
The exercise of share acquisition rights resulted in the issuance of 13,300 shares and increased both stated capital and capital surplus by ¥6.198 million. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 (Note) Increase due to the exercise of stock acquisition rights. 28,420」
The exercise of share acquisition rights resulted in the issuance of 28,420 shares and increased both stated capital and capital surplus by ¥17.073 million. - FY2021AdvancedAnnual report
「As a result of fundraising through the exercise of these share acquisition rights and other factors, cash and cash equivalents at the end of the current consolidated fiscal year amounted to ¥1,253.624 million (¥331.59 million at the end of the previous consolidated fiscal year), while interest-bearing debt amounted to ¥19.17 million (¥125.914 million at the end of the previous consolidated fiscal year).」
Through the issuance of the eighth and ninth series of share acquisition rights and the exercise of the eighth series, the Company recorded ¥773.911 million in proceeds from share issuance during the consolidated fiscal year, increasing cash and cash equivalents to ¥1,253.624 million. - FY2021-Q3AdvancedAnnual report
「Cumulative number of shares delivered upon the exercise of the relevant bonds with share acquisition rights subject to exercise price adjustment as of the end of the quarter 400,000 Cumulative funds raised through the exercise of the relevant bonds with share acquisition rights subject to exercise price adjustment as of the end of the quarter (¥ thousands) 692,267」
The cumulative exercise of the eighth series of share acquisition rights reached 400,000 shares, with cumulative funds raised reaching ¥692.267 million. As a result, cash and cash equivalents at the end of the quarter amounted to ¥1,178.702 million. - FY2021-Q2AdvancedAnnual report
「As a result of fundraising through the partial exercise of these share acquisition rights and other factors, cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year amounted to ¥539.387 million (¥331.59 million at the end of the previous consolidated fiscal year), while interest-bearing debt amounted to ¥19.17 million (¥125.914 million at the end of the previous consolidated fiscal year).」
Fundraising was conducted through the issuance and partial exercise of the eighth and ninth series of share acquisition rights, bringing cash and cash equivalents at the end of the quarter to ¥539.387 million. - FY2021-Q1AdvancedAnnual report
「1 April 2020–30 June 2020 (Note) Increase due to the exercise of stock acquisition rights. 4,000」
The exercise of share acquisition rights resulted in the issuance of 4,000 shares and increased both stated capital and capital surplus by ¥4.8 million. - FY2020AdvancedAnnual report
「The 13,340-share increase in the total number of issued common shares resulted from the exercise of stock options.」
During the fiscal year, the exercise of share acquisition rights resulted in the issuance of 13,340 shares and increased both stated capital and capital surplus by ¥14.302 million. - FY2020-Q2AdvancedAnnual report
「1 July 2019–30 September 2019 3,130 2,109,820 4,069 466,729 4,069 451,729 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 3,130 shares and increased both stated capital and capital surplus by ¥4.069 million. - FY2020-Q1AdvancedAnnual report
「1 April 2019–30 June 2019 7,600 2,106,690 9,120 462,660 9,120 447,660 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 7,600 shares and increased both stated capital and capital surplus by ¥9.12 million. - FY2019AdvancedAnnual report
「1 April 2018–31 March 2019 Common shares 24,850 Common shares 2,099,090 22,807 453,540 22,807 438,540」
The exercise of share acquisition rights, in addition to the public offering and third-party allotment at the time of listing, resulted in the issuance of 24,850 shares and increased both stated capital and capital surplus by ¥22.807 million. - FY2019-Q3AdvancedAnnual report
「The exercise of share acquisition rights increased both stated capital and capital surplus by ¥19.252 million.」
In addition to the public offering and third-party allotment at the time of listing, the exercise of share acquisition rights increased both stated capital and capital surplus by ¥19.252 million. - FY2019-Q2AdvancedAnnual report
「In addition, a third-party allotment of 37,500 shares, conducted in connection with the sale of the Company's shares through an over-allotment, with 20 July 2018 as the payment date, increased both stated capital and capital surplus by ¥27.6 million.」
Following the public offering at the time of listing, a third-party allotment of 37,500 shares was conducted in connection with an over-allotment, increasing both stated capital and capital surplus by ¥27.6 million. - FY2019-Q1First statedAnnual report
「The Company listed on the Tokyo Stock Exchange Mothers market on 21 June 2018. The issuance of 150,000 new shares through a paid public offering (book-building method), with 20 June 2018 as the payment date, increased both stated capital and capital surplus by ¥110.4 million.」
A public offering was conducted in connection with the listing, resulting in the issuance of 150,000 shares and an increase of ¥110.4 million each in stated capital and capital surplus. Subsequent events also describe the use of the proceeds for working capital, including outsourcing expenses, development expenses, recruitment and training expenses, and overseas expansion costs.